Per the NCCN guidelines and clinical trials, the patient does not fit the criteria for low metastatic burden, and therefore the benefit of radiation to the prostate is questionable. (Per NCCN: "Conventional imaging defined number of bony metastases without visceral involvement may be preferred to define candidacy for treatment of the primary tumor".) Would you treat the prostate? Would you treat the lung met? Systemic therapy alone?